近年来，不少中国药企都在通过设立研发总部或枢纽，以加速融入全球创新网络。据了解，2025年以来，齐鲁制药、正大天晴等多家企业研发项目建设就迎来了开工、启用等重要进展。近日，齐鲁制药创新药物全球研发总部项目开工仪式在张江科学城举行。该项目建设聚焦肿瘤、自身免疫、代谢性疾病及神经系统疾病等关键治疗领域，计划搭建小分子药化精准设计、单克隆抗体 / 双特异性抗体、抗体偶联药物(ADC)、小干扰 RNA(...
Source Link近年来，不少中国药企都在通过设立研发总部或枢纽，以加速融入全球创新网络。据了解，2025年以来，齐鲁制药、正大天晴等多家企业研发项目建设就迎来了开工、启用等重要进展。近日，齐鲁制药创新药物全球研发总部项目开工仪式在张江科学城举行。该项目建设聚焦肿瘤、自身免疫、代谢性疾病及神经系统疾病等关键治疗领域，计划搭建小分子药化精准设计、单克隆抗体 / 双特异性抗体、抗体偶联药物(ADC)、小干扰 RNA(...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.